Background: influenza vaccination is recommended for older people irrespective of cognitive decline or residential setting. Objective: to examine the effect of dementia diagnosis on flu vaccination uptake in community and care home residents in England and Wales. Methods: retrospective analysis of a primary care database with 378,462 community and 9,106 care (nursing and residential) home residents aged 65-104 in 2008-09. Predictors of vaccine uptake were examined adjusted for age, sex, area deprivation and major chronic diseases. Results: age and sex standardised uptake of influenza vaccine was 74.7% (95% CI: 73.7-75.8%) in community patients without dementia, 71.4% (69.3-73.5%) in community patients with dementia, 80.5% (78.9-82.2%) in care home patients without dementia and 83.3% (81.4-85.3%) in care home patients with dementia. In a fully adjusted model, compared with community patients without dementia, patients with dementia in the community were less likely to receive vaccination (RR: 0.96, 95% CI: 0.94-0.97) while care home patients with (RR: 1.06, 1.03-1.09) and without (RR: 1.03, 1.01-1.05) dementia were more likely to receive vaccination. Area deprivation and chronic diseases were, respectively, negative and positive predictors of uptake. Conclusion: lower influenza vaccine uptake among community patients with dementia, compared with care home residents, suggests organisational barriers to community uptake but high uptake among patients with dementia in care homes does not suggest concern over informed consent acts as a barrier. Primary care for community patients with dementia needs to ensure that they receive all appropriate preventive interventions.
Introduction
In most developed countries, influenza vaccination is recommended for all older people irrespective of comorbidity or risk [1] . In the UK, a policy of offering influenza vaccination to all older people over 75 was implemented in 1998 followed by extension to all patients aged 65 and over from 2000 [2] . Vaccination is delivered by general practitioners with remuneration based on an item for service model [2] . Prior to 1998, influenza vaccination was targeted to older people with specified co-morbidities and those living in care (nursing and residential) homes. The UK achieves influenza vaccine uptake rates among older people which are higher than most other comparable European countries and the USA [1, 3] . In the 2008-09 influenza season, 74.1% of people aged 65 and over in England received vaccination [4] .
Although UK influenza vaccination guidance does not directly address the issue of dementia, US consensus guidance is clear that vaccination should be offered to all patients with dementia and uptake of influenza vaccination may be a useful marker of access to primary care preventive services [5] . Few studies have examined the effect of dementia diagnosis on the likelihood of receiving vaccination and none has compared both care homes and the community [6] [7] [8] [9] . Specifically, it is not known whether dementia is a barrier to receipt of influenza vaccination, or other preventive interventions, and whether the impact of dementia varies by residential settings. It is likely that barriers to receipt of vaccination will vary in different residential settings.
In this study, we examine differences in uptake of influenza vaccination in England and Wales between patients with and without a diagnosis of dementia in the community and care homes and test the hypotheses that dementia and residential setting modify the likelihood of receiving influenza vaccination.
Methods

Data sources
The Health Improvement Network (THIN, CSD EPIC) database is an established primary care database which collects anonymised data from UK general practices and includes a full record of diagnosis, consultation and prescribing for approximately 5.7% of the UK population [10, 11] . A feature of the THIN database is the family number which allows practices to link patients who live in the same household or institution.
Identifying care home and community residents
Care homes in the UK are classified as either nursing homes, which provide 24-h nursing care in addition to assistance with activities of daily living, or residential homes, which provide help with activities of daily living but are not required to provide care by registered nurses. In the UK, primary care (family) physicians are responsible for the medical care of nursing and residential home residents, including influenza vaccination, but residents are not routinely identified in primary care electronic records. We commissioned anonymised postcode linkage in THIN to identify patients who lived in postcodes which included a nursing or residential home.
Care home residents were identified based on the presence of either a specific record of residence in a care home or at least two other independent markers of care home residence. The independent markers were: (i) registered address in a care home postcode; (ii) a family number with four or more older people in a household or (iii) a record of consultation in a care home. We have previously shown that patients identified through markers are demographically and clinically similar to expectations based on the National census and surveys of UK care homes [12] . Our enhanced detection identifies about 70% of residents in care homes [12] . Patients with no markers of care home residence were identified as living in the community and those with only one independent marker were excluded from the analysis. This ensures that the community comparison group does not include care home patients [12] .
Subjects
We included patients aged 65-104, from 312 practices in England and Wales, who were continually registered between June 2008 and January 2009. This timeframe allows us to examine uptake of influenza during the UK vaccination 'season' of September to January but excludes newly registered patients whose record may be incomplete. The requirement for 8 months continuous registration excludes patients who may be admitted to a care home for end of life care. We identified 9,106 residents in care homes for older people and 378,462 older people in the community.
Vaccination uptake and dementia
Vaccine uptake was identified by the presence of Read codes for vaccination in the primary care record between September 2008 and the end of January 2009. Dementia was identified based on Read codes for dementia used in the national GP contract Quality and Outcomes Framework (QOF) and additional codes for cognitive decline [13] .
Determinants of vaccine uptake
We examined vaccine uptake by age, sex, chronic disease diagnosis, type of care home, national region and area deprivation. Chronic diseases included in the analysis were major indications for influenza vaccination at younger ages: coronary heart disease, heart failure, stroke, COPD, asthma, diabetes and chronic kidney disease. A history of any of these conditions was identified using Read code lists based on the national GP contract QOF [13] .
Care home type was identified through postcode linkage which distinguished whether the care home in the postcode was a nursing or residential home based on national registration data. Geographical region within the UK was categorised as North or South based on general practice location. Our measure of deprivation was the Index of Multiple Deprivation (IMD) 2007, a composite small area ecological measure of deprivation, which was assigned to patients in England based on their postcode and summarised as quintiles based on national ranking [14] .
Analysis
The proportion of patients receiving vaccination was directly standardised for age, in 5-year age bands, and for sex, to the combined care home population. Confidence intervals are based on robust estimates to take account of practice clustering. Determinants of influenza vaccination were examined using a log binomial generalised estimating equation (GEE) [15] . Practice effects were included in the model assuming an exchangeable correlation structure. Two models were implemented. The main model included all patients in a single model and the second model was for care home residents alone to examine any interactions between predictors and residential status.
Results
Subject characteristics
The mean age of care home residents was 85.5 years (86.1 for residential homes, 85.0 for nursing homes) compared with 74.7 for community residents. Among the care home residents 22.4% were male compared with 44.8% in the community. Table 1 shows unadjusted and age and sex standardised uptake of vaccination in the community and care homes, stratified by dementia diagnosis. Uptake was higher in care homes with little difference between nursing and residential homes. In the community, uptake of influenza vaccine was lower among patients with dementia (71.4%, 95% CI: 69.3-73.5%) than patients without dementia (74.7%, 73.7-75.8%). Conversely, in care homes, patients with dementia (83.3%, 81.4-85.3%) had a slightly higher uptake of influenza vaccination than patients without dementia (80.5%, 78.9-82.2%). The age-and sex-adjusted absolute difference in uptake between patients with dementia in the community and care homes was 11.9%. Table 2 shows the predictors of vaccination uptake adjusted for age and sex from the model including all patients. Overall men were more likely to receive vaccination and uptake was lowest in the youngest age group. Uptake was also negatively associated with deprivation while the presence of any co-morbidity increased the likelihood of vaccination. After full adjustment, compared with patients without dementia in the community, patients with dementia in the community remained less likely to receive vaccination (RR: 0.96, 0.94-0.97) while patients with and without dementia in care homes were more likely to receive vaccination (RR: 1.06, 1.03-1.09 for patients with dementia, RR: 1.03, 1.01-1.05 for patients without dementia).
Vaccination uptake
Determinants of influenza vaccination
In a care home only model, age and deprivation did not predict uptake of vaccination and co-morbidity was a weaker predictor (results not shown). However, the effect of dementia was similar in the care home only model, with patients with dementia marginally more likely to receive vaccination (RR: 1.03, 1.01-1.06) compared with patients without dementia in care homes in a fully adjusted model.
Discussion
In this study, overall influenza vaccination uptake is high in both care homes and the community for patients with and without dementia. However, uptake is higher in care homes than the community and patients with dementia in the community are less likely to receive influenza vaccination than patients without dementia. Although differences in uptake related to dementia were small in both settings, the overall impact is that patients with dementia in the community are less likely to receive vaccination than their counterparts in care homes, with a 12% absolute difference in uptake.
Strengths and limitations
We believe this is the first large sample examination of the effect of dementia diagnosis on influenza vaccination uptake and the first study to directly compare community and care home residents in the same sample. As our analysis is based on unselected primary care patients, compared with survey-based studies, our findings are not subject to non-response bias which may be a particular issue for patients with cognitive impairment [6, 7, 16] . The representativeness of our study is confirmed by the almost identical uptake in our community sample (74.4%) to nationally published figures based on returns from 96% of practices in England (74.1%). As influenza vaccination for older people is almost exclusively delivered through primary care in the UK, recording of influenza vaccine uptake is likely to be complete in our primary care data. The main limitation of our work is the completeness of recording of dementia diagnosis in the community. Incomplete identification and recording of dementia in primary care is well recognised and our community prevalence is below expectations from epidemiological surveys [17] . Any under-recording of dementia in the community would tend to attenuate differences in vaccine uptake between patients with and without a dementia diagnosis. This means that our finding that community dementia patients are less likely to receive vaccination is robust and, if anything, under-estimates the effect of dementia on vaccination uptake. Our earlier work suggests that dementia is well recorded in care home residents with similar prevalence in our study to survey-based estimates [12] . This means our estimate for the effect of dementia in care homes is unlikely to be biased by under-recording of dementia.
We have adjusted our analysis for important determinants of vaccination uptake, including co-morbidity and deprivation. We have not adjusted for contact with health services as we believe that this is part of the causal pathway for vaccination uptake in that contact will increase the likelihood of opportunistic vaccination. Specifically, if community patients with dementia were less likely to receive vaccination as a result of less contact with health services, adjustment would inappropriately mask this effect.
Comparison with other literature
Our overall findings on determinants of influenza uptake are consistent with existing community-based studies from a number of countries in terms of the effect of deprivation and existing chronic disease [2, 6, 7, 16, 18, 19] . Our observation that men are slightly more likely to receive vaccination has been reported in some UK studies [2] , but, interestingly, is different from another UK primary care database study which suggested that men were less likely to receive vaccination [18] .
The effect of dementia on influenza vaccine uptake has not been widely studied. One community-based UK survey, undertaken in 2000, found that patients with a low cognitive function score were less likely to receive vaccination but did not report directly on the effect of dementia diagnosis and focused on patients aged over 75 only 2 years after introduction of universal vaccination for this age group [6] . A Canadian survey, which excluded patients with dementia, found that patients with lower cognitive function scores were marginally less likely to receive influenza vaccination [7] .
In care homes, one US study reported that patients with cognitive impairment were more likely to receive vaccination but another larger study found no effect in an adjusted analysis [8, 9] .
Implications
High overall uptake of vaccination, close to or exceeding the WHO target of 75%, in both care homes and the community and for patients with and without dementia confirms the effectiveness of the UK vaccination policy in comparison with other developed countries [1, 3] . The high uptake of influenza vaccination in nursing and residential homes probably reflects the long-standing recommendation for vaccinations in these settings and the logistical simplicity of vaccinating older people in a single institution. This high uptake contrasts with concerns over access to chronic disease management in care homes [20] . It is noteworthy that influenza vaccination is one of few specific, incentivised healthcare interventions for care home residents in the UK and suggests that focused and incentivised initiatives may be effective in care homes. An intriguing finding is that, in care homes, patients with dementia are marginally more likely to receive vaccination. We cannot easily explain this difference as access should be similar for all patients in care homes. Although a small difference, our finding that older people with dementia in the community have the lowest vaccine uptake suggests poorer access to preventive care for people with dementia living in their own homes. The paradoxically higher vaccination uptake for patients with dementia in care homes does not suggest that this lower community uptake can be easily explained by informed clinician and carer decisions, based on capacity to benefit or dementia severity. Lower community uptake is more likely to result from organisational, rather than patient or clinical, factors and understanding barriers to uptake is essential for improving care for patients with dementia and improving overall community vaccine uptake.
A small survey of old age psychiatrists had identified concerns over the use of influenza vaccination in older people with dementia in long-term care related to capacity for informed consent and appropriateness of preventive interventions which improve survival [21] . Again, our high vaccine uptake in patients with dementia in care homes does not support the hypothesis that capacity for informed consent acts as a barrier to influenza vaccination in the community or care homes.
Although, there is legitimate debate over the appropriateness of preventive interventions for patients with advanced dementia, consensus views support the use of influenza vaccination in advanced dementia [5, 21] . Indeed, community patients with dementia are likely to benefit more from vaccination than other patients as influenza will increase hospitalisation, illness in carers and strain on carers, which may precipitate a breakdown of care arrangements and admission to long-term care.
Lower uptake of influenza vaccine in the community questions the organisation and effectiveness of preventive care for patients with dementia in the community and it is plausible that our finding of lower vaccination uptake apply to other groups of vulnerable older people. Organisational barriers, including arrangements for domiciliary care and the ability of community nursing staff to offer vaccination, are potential explanations for the difference in uptake between patients with dementia in care homes and community. Strain and demands on carers may also contribute to lower uptake in the community and this has been reported as a determinant of vaccination in older men with dementia [22] .
Primary care teams need to examine organisational arrangements for delivering care for patients with dementia, including support for carers, to ensure that this vulnerable group are not inadvertently excluded from effective generic health interventions.
Key points
• Influenza vaccination is recommended for all older people, but there is limited information on the effect of dementia diagnosis and residential setting on uptake.
• Vaccine uptake is >70% in both care homes and the community and for older people with and without dementia with the highest uptake in care homes.
• Uptake of influenza vaccine by patients with dementia living in the community is lower than both patients without dementia in the community and care home residents.
• High uptake by patients with dementia in care homes does not suggest that concerns over consent act as a barrier to vaccination uptake for patients with dementia.
• Primary care needs to identify and reduce organisational barriers to uptake of influenza vaccination, and other preventive interventions, by patients with dementia in the community.
S.S. had the idea for the study and led the project. I.C. undertook the analysis. All authors contributed to the development of the project methodology, interpretation of the results and drafting of the paper. S.S. is the guarantor for the paper.
Conflicts of Interest
None.
Ethical approval
The study was approved by the South-East Multicentre Research Ethics Committee. (study reference: 08/H1102/ 33).
Funding
The study was funded by a grant from the BUPA Foundation, an independent medical research charity. The funder had no role in the design, execution, analysis, interpretation or writing of this paper.
